We are drowning in numbers, and we no longer understand what they mean. Every day, headlines bombard us with figures meant to inform: billions in spending, trillions in debt, percentages signaling growth or decline. But for most of us, these numbers blur together. They register as “large” or “small,” but almost never as real. And that is more than a math problem. It is a civic one.
INFORMS has awarded Microsoft (NASDAQ: MSFT) its 2026 Franz Edelman Award for Achievement in Advanced Analytics, Operations Research and Management Science, for reengineering how global cloud infrastructure is planned and delivered, applying advanced analytics and AI to orchestrate complex fulfillment decisions across its rapidly expanding data center network.
In the rush to adopt artificial intelligence, many employers are now requiring that employees use AI tools. As you’re using AI, be intentional and selective. It’s critical that you know yourself. Research published in Management Science found that AI is most valuable for people who understand their own abilities and limitations. Assess yourself, so you can factor this into your process for incorporating AI into your work.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
The airline industry has been a major beneficiary of the vaccine euphoria. First Pfizer, then Moderna announced vaccine candidates with a promised effectiveness of 90% or more. This excited investors and airline executives alike, with visions of pent-up demand creating packed planes with filled middle seats.
Another wave of COVID-19 cases is now triggering another wave of panic buying across the country. But the Maryland Department of Commerce says it has no regulatory oversight on grocers in the state. At this point, it's up to each individual company to set purchasing limits on high-demand items. In some instances, stores are starting to see empty shelves again.
Scientists work at the mAbxience biosimilar monoclonal antibody laboratory plant in Garin, Buenos Aires province, on August 14, 2020, where an experimental coronavirus vaccine will be produced for Latin America. - Argentina will manufacture while Mexico will pack and distribute in Latin America, except of Brazil, the vaccine against COVID-19 developed by the University of Oxford and the AstraZeneca laboratory.
Two drug companies have now reported highly successful results from phase III trials of COVID-19 vaccines. On November 18 Pfizer and partner BioNTech said their vaccine was 95 percent effective at preventing the disease, based on full trial results. Two days earlier Moderna reported its vaccine was 94.5 percent effective, based on interim data.
It’s probably not exactly what President Donald Trump meant when he borrowed the historic jingoistic slogan “America First” for his administration, but since early in the global COVID-19 pandemic, the U.S. has consistently held the Number One spot in coronavirus cases and deaths. It took less than two months for these numbers to grow from 200,000 to a mind-boggling 250,000 now.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine